COMPARISON OF OUTCOMES AFTER DONOR LYMPHOCYTE INFUSION WITH OR WITHOUT PRIOR CHEMOTHERAPY FOR MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Mo, X. -D. [1 ]
Zhang, X. -H. [1 ]
Xu, L. -P. [1 ]
Wang, Y. [1 ]
Yan, C. -H. [1 ]
Chen, H. [1 ]
Chen, Y. -H. [1 ]
Han, W. [1 ]
Wang, F. -R. [1 ]
Wang, J. -Z. [1 ]
Liu, K. -Y. [1 ]
Huang, X. -J. [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Inst Hematol, Beijing, Peoples R China
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1515
引用
收藏
页码：618 / 618
页数：1
相关论文
共 50 条
  • [41] Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation
    Tsirigotis, P.
    Danylesko, I.
    Gkirkas, K.
    Shem-Tov, N.
    Yerushalmi, R.
    Stamouli, M.
    Avigdor, A.
    Spyridonidis, A.
    Gauthier, J.
    Goldstein, G.
    Apostolidis, J.
    Mohty, M.
    Shimoni, A.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (10) : 1313 - 1317
  • [42] Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation
    P Tsirigotis
    I Danylesko
    K Gkirkas
    N Shem-Tov
    R Yerushalmi
    M Stamouli
    A Avigdor
    A Spyridonidis
    J Gauthier
    G Goldstein
    J Apostolidis
    M Mohty
    A Shimoni
    A Nagler
    Bone Marrow Transplantation, 2016, 51 : 1313 - 1317
  • [43] MINIMAL RESIDUAL DISEASE MONITORING AND PREEMPTIVE IMMUNOTHERAPY IN MYELODYSPLASTIC SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Mo, X. D.
    Qin, Y. Z.
    Zhang, X. H.
    Xu, L. P.
    Wang, Y.
    Yan, C. H.
    Chen, H.
    Chen, Y. H.
    Han, W.
    Wang, F. R.
    Wang, J. Z.
    Liu, K. Y.
    Huang, X. J.
    HAEMATOLOGICA, 2016, 101 : 501 - 501
  • [44] Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
    Mo, Xiao-Dong
    Qin, Ya-Zhen
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Liu, Kai-Yan
    Huang, Xiao-Jun
    ANNALS OF HEMATOLOGY, 2016, 95 (08) : 1233 - 1240
  • [45] DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN: SINGLE CENTER EXPERIENCE
    Park, J. E.
    Lee, K. C.
    Jung, H. J.
    Lee, S. W.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S494 - S494
  • [46] Adoptive immunotherapy with donor lymphocyte infusion after allogeneic nonmyeloablative stem cell transplantation.
    Qiao, ZH
    Zheng, ZZ
    Ye, F
    Ma, LM
    Gong, R
    BLOOD, 2005, 106 (11) : 383B - 383B
  • [47] Donor lymphocyte infusions for the treatment of relapse after allogeneic hematopoietic stem cell transplantation.
    Riera, L
    Koziner, B
    MEDICINA-BUENOS AIRES, 2000, 60 (02) : 259 - 269
  • [48] Donor lymphocyte infusions in patients with leukemia after allogeneic hematopoietic stem cell transplantation.
    Liu, QF
    Sun, J
    Liu, YL
    Zhou, SY
    BLOOD, 2002, 100 (11) : 448B - 448B
  • [49] Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
    Kaito Harada
    Shohei Mizuno
    Shingo Yano
    Akiyoshi Takami
    Hiroto Ishii
    Kazuhiro Ikegame
    Yuho Najima
    Shinichi Kako
    Takashi Ashida
    Souichi Shiratori
    Shuichi Ota
    Makoto Onizuka
    Kentaro Fukushima
    Takahiro Fukuda
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Masamitsu Yanada
    Annals of Hematology, 2022, 101 : 643 - 653
  • [50] Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
    Harada, Kaito
    Mizuno, Shohei
    Yano, Shingo
    Takami, Akiyoshi
    Ishii, Hiroto
    Ikegame, Kazuhiro
    Najima, Yuho
    Kako, Shinichi
    Ashida, Takashi
    Shiratori, Souichi
    Ota, Shuichi
    Onizuka, Makoto
    Fukushima, Kentaro
    Fukuda, Takahiro
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yanada, Masamitsu
    ANNALS OF HEMATOLOGY, 2022, 101 (03) : 643 - 653
12345